Skip to content

Clinical trials

Fallopian Tube Neoplasms trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Country / region: Poland Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20101
20111
20132
20172
20182
20191
20201
20212
20221
20231
20241
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting7
Active, not recruiting5
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie3
Merck Sharp & Dohme LLC3
pharmaand GmbH3
Affidea Nu-med Center of Oncological DIagnostics and Therapy2
Amgen2
Corcept Therapeutics2
Eli Lilly and Company2
Daiichi Sankyo1
Genmab1
Glycotope GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms25
Ovarian Neoplasms21
Carcinoma, Ovarian Epithelial9
Peritoneal Neoplasms9
Neoplasms4
Endometrial Neoplasms2
Recurrence2
Uterine Cervical Neoplasms2
Uterine Neoplasms2
Vaginal Neoplasms2

Trials

Showing 51 to 25 of 25. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.